CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-20 | SUMMER ROAD LLC 10% owner | Purchase | +17,948 | $5.70 | $102K | 5,832,709 |
| 2022-01-18 | SUMMER ROAD LLC 10% owner | Purchase | +6,807 | $6.00 | $41K | 5,814,761 |
| 2022-01-14 | SUMMER ROAD LLC 10% owner | Purchase | +33,193 | $6.03 | $200K | 5,807,954 |
| 2022-01-13 | SUMMER ROAD LLC 10% owner | Purchase | +10,000 | $6.20 | $62K | 5,774,761 |
| 2021-12-15 | SUMMER ROAD LLC 10% owner | Purchase | +15,000 | $6.22 | $93K | 5,764,761 |
| 2021-12-14 | SUMMER ROAD LLC 10% owner | Purchase | +29,490 | $6.41 | $189K | 5,749,761 |
| 2021-12-13 | SUMMER ROAD LLC 10% owner | Purchase | +10,510 | $6.50 | $68K | 5,720,271 |
| 2021-12-10 | SUMMER ROAD LLC 10% owner | Purchase | +30,000 | $6.65 | $199K | 5,709,761 |
| 2021-12-08 | SUMMER ROAD LLC 10% owner | Purchase | +5,300 | $6.75 | $36K | 5,679,761 |
| 2021-12-06 | SUMMER ROAD LLC 10% owner | Purchase | +55,600 | $6.13 | $341K | 5,674,461 |
| 2021-10-01 | White Christopher G Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-09-20 | RAINES MERILEE Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2021-08-20 | Mattessich Antony C. President and CEO | Purchase | +5,000 | $9.89 | $49K | 102,900 |
| 2021-06-18 | Williams Leslie J. Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-18 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-18 | PEACOCK BRUCE Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-18 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-18 | Hong Seung Suh Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-18 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-05-20 | LINDSTROM RICHARD L MD Director | Sale | −10,000 | $14.30 | $143K | 90,000 |
Page 14 of 17 · 327 trades